English Court of Appeal confirms Cubist’s patent loss

23-01-2018

English Court of Appeal confirms Cubist’s patent loss

AndreyPopov / iStockphoto.com

The English Court of Appeal has confirmed the revocation of Cubist Pharmaceuticals’ patent relating to antibiotic product daptomycin, on the basis of obviousness.


Cubist, Hospira, patent revocation, Daptomycin, English Court of Appeal

LSIPR